Positron Corporation (POSC)
USD 1.57
(-16.49%)
USD 1.57
(-16.49%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1 Million USD | -61.28% |
| 2022 | 2.6 Million USD | 190.17% |
| 2021 | 896.42 Thousand USD | 302.25% |
| 2020 | 222.85 Thousand USD | 8.09% |
| 2019 | 206.16 Thousand USD | 301.96% |
| 2018 | 51.29 Thousand USD | 0.0% |
| 2014 | 2.84 Million USD | -24.32% |
| 2013 | 3.76 Million USD | -32.23% |
| 2012 | 5.55 Million USD | 18.89% |
| 2011 | 4.66 Million USD | -67.81% |
| 2010 | 14.5 Million USD | 192.64% |
| 2009 | 4.95 Million USD | -34.04% |
| 2008 | 7.51 Million USD | -1.04% |
| 2007 | 7.59 Million USD | 64.96% |
| 2006 | 4.6 Million USD | 82.22% |
| 2005 | 2.52 Million USD | 1.08% |
| 2004 | 2.49 Million USD | 3.14% |
| 2003 | 2.42 Million USD | -26.2% |
| 2002 | 3.28 Million USD | 0.12% |
| 2001 | 3.27 Million USD | -13.73% |
| 2000 | 3.8 Million USD | 98.28% |
| 1999 | 1.91 Million USD | 12.76% |
| 1998 | 1.7 Million USD | -71.47% |
| 1997 | 5.95 Million USD | -20.45% |
| 1996 | 7.49 Million USD | 7.0% |
| 1995 | 7 Million USD | 1.45% |
| 1994 | 6.9 Million USD | 53.33% |
| 1993 | 4.5 Million USD | -4.26% |
| 1992 | 4.7 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 400.35 Thousand USD | 40.76% |
| 2023 Q4 | 284.41 Thousand USD | -21.73% |
| 2023 Q1 | 107.46 Thousand USD | 30.25% |
| 2023 Q3 | 363.39 Thousand USD | 83.23% |
| 2023 FY | 1 Million USD | -61.28% |
| 2023 Q2 | 198.32 Thousand USD | 84.56% |
| 2022 Q3 | 375.4 Thousand USD | 262.43% |
| 2022 Q1 | 1.29 Million USD | 1602.58% |
| 2022 FY | 2.6 Million USD | 190.17% |
| 2022 Q2 | 103.58 Thousand USD | -91.99% |
| 2022 Q4 | 82.5 Thousand USD | -78.02% |
| 2021 Q4 | 75.94 Thousand USD | -69.06% |
| 2021 Q3 | 245.45 Thousand USD | -13.31% |
| 2021 Q2 | 283.13 Thousand USD | -3.0% |
| 2021 Q1 | 291.88 Thousand USD | 0.0% |
| 2021 FY | 896.42 Thousand USD | 302.25% |
| 2020 FY | 222.85 Thousand USD | 8.09% |
| 2020 Q2 | 50.82 Thousand USD | 0.0% |
| 2019 FY | 206.16 Thousand USD | 301.96% |
| 2018 FY | 51.29 Thousand USD | 0.0% |
| 2015 Q1 | 667 Thousand USD | -0.6% |
| 2015 Q3 | 277 Thousand USD | -23.27% |
| 2015 Q2 | 361 Thousand USD | -45.88% |
| 2014 Q2 | 752 Thousand USD | 5.47% |
| 2014 FY | 2.84 Million USD | -24.32% |
| 2014 Q4 | 671 Thousand USD | -5.63% |
| 2014 Q3 | 711 Thousand USD | -5.45% |
| 2014 Q1 | 713 Thousand USD | -46.79% |
| 2013 Q1 | 894 Thousand USD | -11.4% |
| 2013 Q2 | 672 Thousand USD | -24.83% |
| 2013 FY | 3.76 Million USD | -32.23% |
| 2013 Q3 | 857 Thousand USD | 27.53% |
| 2013 Q4 | 1.34 Million USD | 56.36% |
| 2012 Q3 | 909 Thousand USD | -38.25% |
| 2012 FY | 5.55 Million USD | 18.89% |
| 2012 Q2 | 1.47 Million USD | -31.88% |
| 2012 Q4 | 1 Million USD | 11.0% |
| 2012 Q1 | 2.16 Million USD | 132.87% |
| 2011 Q3 | 1.08 Million USD | -27.79% |
| 2011 FY | 4.66 Million USD | -67.81% |
| 2011 Q4 | 928 Thousand USD | -14.15% |
| 2011 Q2 | 1.49 Million USD | 28.72% |
| 2011 Q1 | 1.16 Million USD | -13.85% |
| 2010 Q1 | 3.43 Million USD | 52.72% |
| 2010 FY | 14.5 Million USD | 192.64% |
| 2010 Q3 | 2.52 Million USD | -64.57% |
| 2010 Q4 | 1.35 Million USD | -46.45% |
| 2010 Q2 | 7.11 Million USD | 107.43% |
| 2009 FY | 4.95 Million USD | -34.04% |
| 2009 Q3 | 1.07 Million USD | 9.48% |
| 2009 Q2 | 981 Thousand USD | 49.77% |
| 2009 Q1 | 655 Thousand USD | -84.75% |
| 2009 Q4 | 2.24 Million USD | 109.12% |
| 2008 Q2 | 960 Thousand USD | -29.62% |
| 2008 Q3 | 895 Thousand USD | -6.77% |
| 2008 Q4 | 4.29 Million USD | 379.89% |
| 2008 Q1 | 1.36 Million USD | -60.58% |
| 2008 FY | 7.51 Million USD | -1.04% |
| 2007 FY | 7.59 Million USD | 64.96% |
| 2007 Q4 | 3.46 Million USD | 154.22% |
| 2007 Q1 | 1.43 Million USD | -38.87% |
| 2007 Q2 | 1.33 Million USD | -6.69% |
| 2007 Q3 | 1.36 Million USD | 1.72% |
| 2006 Q2 | 936 Thousand USD | 4.58% |
| 2006 FY | 4.6 Million USD | 82.22% |
| 2006 Q1 | 895 Thousand USD | 48.67% |
| 2006 Q3 | 425 Thousand USD | -54.59% |
| 2006 Q4 | 2.34 Million USD | 452.0% |
| 2005 FY | 2.52 Million USD | 1.08% |
| 2005 Q4 | 602 Thousand USD | -2.11% |
| 2005 Q2 | 712 Thousand USD | 19.26% |
| 2005 Q3 | 615 Thousand USD | -13.62% |
| 2005 Q1 | 597 Thousand USD | -25.09% |
| 2004 Q1 | 371 Thousand USD | -22.71% |
| 2004 Q3 | 591 Thousand USD | -20.14% |
| 2004 Q4 | 797 Thousand USD | 34.86% |
| 2004 FY | 2.49 Million USD | 3.14% |
| 2004 Q2 | 740 Thousand USD | 99.46% |
| 2003 Q2 | 666 Thousand USD | -1.48% |
| 2003 Q4 | 480 Thousand USD | -20.13% |
| 2003 FY | 2.42 Million USD | -26.2% |
| 2003 Q3 | 601 Thousand USD | -9.76% |
| 2003 Q1 | 676 Thousand USD | -8.03% |
| 2002 Q4 | 735 Thousand USD | -11.02% |
| 2002 Q1 | 714 Thousand USD | -11.41% |
| 2002 Q2 | 1 Million USD | 41.18% |
| 2002 Q3 | 826 Thousand USD | -18.06% |
| 2002 FY | 3.28 Million USD | 0.12% |
| 2001 Q1 | 948 Thousand USD | -12.71% |
| 2001 Q4 | 806 Thousand USD | 7.61% |
| 2001 Q2 | 776 Thousand USD | -18.14% |
| 2001 FY | 3.27 Million USD | -13.73% |
| 2001 Q3 | 749 Thousand USD | -3.48% |
| 2000 Q3 | 951 Thousand USD | 11.75% |
| 2000 FY | 3.8 Million USD | 98.28% |
| 2000 Q2 | 851 Thousand USD | -6.79% |
| 2000 Q1 | 913 Thousand USD | 0.0% |
| 2000 Q4 | 1.08 Million USD | 14.2% |
| 1999 FY | 1.91 Million USD | 12.76% |
| 1998 FY | 1.7 Million USD | -71.47% |
| 1997 Q1 | 1.8 Million USD | 0.56% |
| 1997 FY | 5.95 Million USD | -20.45% |
| 1996 Q3 | 2.1 Million USD | 16.67% |
| 1996 Q4 | 1.79 Million USD | -14.76% |
| 1996 FY | 7.49 Million USD | 7.0% |
| 1996 Q2 | 1.8 Million USD | -5.26% |
| 1996 Q1 | 1.9 Million USD | 0.0% |
| 1995 Q2 | 1.8 Million USD | 12.5% |
| 1995 Q1 | 1.6 Million USD | -36.0% |
| 1995 Q4 | 1.9 Million USD | 5.56% |
| 1995 Q3 | 1.8 Million USD | 0.0% |
| 1995 FY | 7 Million USD | 1.45% |
| 1994 Q2 | 1.4 Million USD | -6.67% |
| 1994 Q1 | 1.5 Million USD | 130.61% |
| 1994 FY | 6.9 Million USD | 53.33% |
| 1994 Q3 | 1.4 Million USD | 0.0% |
| 1994 Q4 | 2.5 Million USD | 78.57% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 FY | 4.5 Million USD | -4.26% |
| 1993 Q4 | -4.9 Million USD | 0.0% |
| 1993 Q1 | - USD | 100.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q4 | -6.9 Million USD | 0.0% |
| 1992 FY | 4.7 Million USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -35.995% |
| IR-Med Inc. | 4.89 Million USD | 79.418% |
| Polarean Imaging plc | 12.24 Million USD | 91.772% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 23.719% |
| Avitar, Inc. | 3.56 Million USD | 71.781% |
| AVITA Medical, Inc. | 80.77 Million USD | 98.753% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -43.284% |
| Össur hf. | 396.18 Million USD | 99.746% |
| Zecotek Photonics Inc. | 3.46 Million USD | 70.9% |
| QHSLab, Inc. | 961.65 Thousand USD | -4.745% |
| Wellstar International, Inc. | 1.79 Million USD | 43.874% |
| Össur hf. | 396.18 Million USD | 99.746% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 95.375% |
| Escalon Medical Corp. | 5.25 Million USD | 80.816% |
| Aurora Spine Corporation | 8.65 Million USD | 88.365% |
| BrainsWay Ltd. | 28.01 Million USD | 96.405% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 89.468% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 97.0% |
| Vivos Inc. | 2.78 Million USD | 63.859% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.904% |
| Kelyniam Global, Inc. | 2.27 Million USD | 55.728% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 0.751% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -131.294% |
| Nanomix Corporation | 8.36 Million USD | 87.962% |
| Theraclion SA | 7.43 Million USD | 86.461% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 22.192% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 67.616% |
| Lombard Medical, Inc. | 30.29 Million USD | 96.675% |
| ALR Technologies Inc. | 6.33 Million USD | 84.102% |
| Stratec SE | 46.32 Million USD | 97.825% |
| Vycor Medical, Inc. | 1.27 Million USD | 21.026% |
| Heart Tronics, Inc. | 14.46 Million USD | 93.034% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -735.741% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -387.981% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 92.882% |
| VMS Rehab Systems, Inc. | 63.63 USD | -1582934.732% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 71.163% |
| Ingen Technologies, Inc. | 1.88 Million USD | 46.484% |
| Odyssey Group International, Inc. | -14.26 Million USD | 107.063% |
| United American Healthcare Corporation | 59 Thousand USD | -1607.263% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -147.196% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -58.706% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 40.593% |
| Urologix, Inc. | 10.09 Million USD | 90.019% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 20.268% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 83.066% |
| SS Innovations International, Inc. | 21.38 Million USD | 95.289% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -337.492% |
| Smith & Nephew plc | 3.46 Billion USD | 99.971% |
| NIOX Group Plc | 22.27 Million USD | 95.478% |
| Fuse Medical, Inc. | 10.35 Million USD | 90.268% |
| Broncus Holding Corporation | 38.15 Million USD | 97.36% |
| Brain Scientific Inc. | 9.66 Million USD | 89.576% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 90.223% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -1559.503% |